BETALOC TABLET 100MG

Ülke: Malezya

Dil: İngilizce

Kaynak: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

şimdi satın al

Ürün özellikleri Ürün özellikleri (SPC)
19-12-2017

Aktif bileşen:

METOPROLOL TARTRATE

Mevcut itibaren:

ASTRAZENECA SDN. BHD.

INN (International Adı):

METOPROLOL TARTRATE

Paketteki üniteler:

100Tablet Tablets; 100 Tablet Tablets

Tarafından üretildi:

AstraZeneca Pharmaceutical Co. Ltd.

Ürün özellikleri

                                1
Betaloc Tablet
Metoprolol tartrate
Composition
1 tablet contains	: 50 and 100 mg metoprolol tartrate respectively.
For a complete list of excipients	, see	List of excipients	.
Pharmaceutical form
Tablet	.
50 mg tablet	s: W	hite	, round with a diameter of 8 mm	, bisected	, marked A/BB	. The score	mark
is	not intended to divide the tablet into two equal doses. It is	only to facilitate	swallowing	.
100 mg tablet	s: W	hite	, round	with a diameter of 10 mm	, bisected, mark	ed	A/	M	E. The	tablet
can be divided into	two	equal	doses	.
Therapeutic indication	s
Hypertension	: to	reduce blood pressure and to reduce the risk of cardiovascular and coronary
mortality (including sudden death)	, and morbidity.
Angina pectoris.
Disturbances of cardiac rhythm including especially supraventricular tachycardia.
Confirmed or suspected m	yocardial infarction	- prevention of cardiac death and reinfarction.
Functional heart disorders with palpitations.
Migraine prophylaxis	.
Hyperthyroidism.
Posology and Method of Administration
Dosage should be adjusted individually to avoid	bradycardia. The tablets should be taken on
an empty stomach. Concomitant intake of food increases the bioavailability of metoprolol
with 40 %. The following is valid as guidelines:
Hypertension
100	-200 mg daily divided on one or two occasions. The table	ts should be taken in the morning
if once	-daily dosage. In patients not responding to 200 mg, the dose could be combined with
other antihypertensive agents, preferably diuretics and calcium antagonists of the
dihydropyridine type, or increased.
                                
                                Belgenin tamamını okuyun
                                
                            

Diğer dillerdeki belgeler

Bilgilendirme broşürü Bilgilendirme broşürü Malayca 19-07-2019

Bu ürünle ilgili arama uyarıları

Belge geçmişini görüntüleyin